W ithout question, the medical management of chronic pain patients presents primary care practitioners with signifi cant challenges. Often these patients do not improve to the point that they no longer require medication management and other routine medical services (1) . Th ese patients also generally take up a disproportionate amount of the practitioner's time at offi ce visits, and they are often uninsured and/or have limited fi nancial means. It is also well publicized that state and federal authorities, primarily the Texas Medical Board (TMB), have made the evaluation of medical treatment of chronic pain a focus of their policing authority (2) . Unfortunately, the current form-over-substance approach of the TMB and other regulatory agencies may be a major reason for primary practitioners' fl ight from seeing chronic pain patients. In spite of the fact that TMB rules specifi cally provide that the substance of a practitioner's actions should trump the rules' documentation (form) requirements (3) , this directive is frequently not followed by the TMB when evaluating medical treatment of chronic pain patients. Against these disincentives to handle chronic pain patients are sentiments that chronic pain is frequently undertreated and/or inadequately managed (4) .
Th ese circumstances place primary care practitioners in a diffi cult and unenviable situation. Primary care providers are frequently the only health care provider a patient wants to see or can aff ord to see. Th us, primary providers are often a chronic pain patient's only hope. Most providers have a true desire to help these patients, but many times this desire is outweighed by the disincentives mentioned above.
Th ese circumstances have appeared to stratify primary care practitioners into three classes. Th e fi rst is a small class of practitioners who have decided to fi ght for these patients. Th e second is a class of practitioners who want to do the right thing but are understandably intimidated by entities like the TMB and are not sure what to do. Th ose in the third group have decided that these patients are simply not worth the practical and regulatory headaches. Th e primary aim here is to provide some pointers to the second and third classes of providers so these patients will not become orphans, and to provide some insight to help protect the fi rst class of providers.
Medicolegal Issues

TEXAS MEDICAL BOARD RULES
Th e fi rst thing any provider who treats a chronic pain patient needs to do is to spend about 20 to 30 minutes reading the TMB guidelines on pain management ("guidelines") (5). Th ese guidelines cover only 4 pages, so 20 to 30 minutes is probably much more than one would need to digest this information. Th ese guidelines are easily accessible through the TMB's website at http://www.tmb.state.tx.us/rules/rules.php.
Th ere are several key points to take away from the guidelines. First and foremost, chronic pain treatment must be based on "sound clinical judgment" (6) . Th e guidelines provide that sound clinical judgment "results from evidence-based medicine and/or the use of generally accepted standards of care" (6) . Th is directive is the most problematic for practitioners in TMB proceedings because "generally accepted standards of care" is an extremely subjective and nonspecifi c concept. Like beauty, what is a generally accepted standard of care is in the eye of the beholder. Th is diffi cult situation is even further complicated by the fact that in TMB proceedings, the experts retained by the TMB to review cases often do a pretty shoddy job of reviewing the relevant records and information provided. In my experience, TMB expert reviewers almost routinely level at least one criticism (and oftentimes more) that is directly refuted by objective data in the materials provided.
Th e guidelines do provide some very explicit statements that support those who endeavor to treat chronic pain. Th ese statements include:
• "Patients deserve to have medical treatment for their pain, whether the pain is acute, or chronic, mild or severe" (7).
• "Drugs, including opiates, are essential tools for the treatment of pain" (8).
• "Physicians should not fear board action if they provide proper pain treatment. Th e board will not look solely at the quantity or duration of therapy" (9) . In addition to these background principles, the guidelines provide some specifi c benchmarks that are used to assess a practitioner's treatment of chronic pain (10) . Th ese benchmarks include the initial and follow-up evaluation of the patient, the need for a treatment plan, documentation of informed consent related to the treatment provided, and periodic review of the treatment plan. Th e guidelines also speak of a formal chronic pain agreement and consultations and referrals.
On fi rst blush, these guidelines might seem burdensome. Th e fact of the matter, however, is that the information required by the guidelines is already routinely obtained and considered by providers. Th e issue is just a matter of realizing what is important under this unique circumstance and having your documentation set you up for success rather than failure.
Th e thing to keep in mind here is your likely audience. Th at audience will likely be a licensing board that is skeptical towards chronic pain and that tends to look at form over substance. Another unfortunate reality is the fact that the "experts" utilized by the TMB to review such matters appear to search for problems. Reviewers do not seem focused on an objective evaluation of the circumstances or really looking to see if the patient's treatment is justifi ed. Th e TMB's expert reviewers appear to look for "holes" in the documentation. If a hole exists, a violation of the standard of care is dogmatically asserted, despite the fact that a considered review of the pertinent materials would reasonably support the treatment provided. Th is failure to approach the review in an impartial and objective manner unfairly places the practitioner at a disadvantage from the outset and places even more emphasis on documentation.
More often than not, providers who are criticized for their management of a patient's chronic pain actually provided reasonable treatment. Th e problem is that they failed to adequately document the reasons for their actions, or lack thereof. Providers are most frequently criticized for not having a "treatment plan" and for not having shown that the use of narcotic medications was "therapeutic," meaning that it was of benefi t to the patient. With these thoughts in mind, here are some suggestions on how to adequately, validly, and quickly provide some of the key documentation that will help you in the event your actions are later reviewed.
MANAGING THE GUIDELINES
I would like to primarily focus on two guideline requirements: the initial patient history requirement and the treatment plan requirement.
Th e guidelines require the initial patient history to include the (a) nature and intensity of pain, (b) current and past treatments, (c) underlying and/or comorbid conditions, (d) eff ect of chronic pain on the patient, (e) history or concerns about substance abuse, and (f ) indications for use of a narcotic or similar scheduled medication (11) . Candidly, this is not a burdensome requirement. Any decent initial history should pretty much cover these areas. Th e thing here is to appreciate the information that will really help if your actions are later reviewed. Th e "current and past treatments" and "eff ect of chronic pain treatment on the patient" history requirements merit particular attention.
Complete documentation of the patient's current and past treatments is important because it allows the practitioner to set the framework through which his treatment plan and subsequent actions should be evaluated. For example, documentation that the patient has had prior extensive evaluation and workup (including documentation of the specifi cs of that prior evaluation and workup) should raise the threshold at which consultation and referral for other treatment options are needed and provide justifi cation from the outset for a plan that may simply involve long-term medication use. In contrast, if the patient has no prior evaluation or workup, the burden falls on the practitioner to diagnose the underlying cause of the patient's pain, and the threshold for recommending consultation and referral regarding the existence of defi nitive therapy is very low.
Complete documentation of the eff ects of chronic pain on the patient is another area that provides the practitioner a signifi cant benefi t if his or her conduct is reviewed in the future. By thoroughly documenting how chronic pain is adversely affecting the patient, the practitioner has from the outset many avenues through which to substantiate the benefi t of his or her treatment of this patient's chronic pain.
Th e most frequent omission I see in chronic pain patient records is documentation of how the pain aff ects the patient. Without question, the burden of chronic pain is not limited to the fact that the patient must deal with constant pain. Chronic pain not only hurts patients, it prevents them from functioning; that is to say, they cannot do things they need or want to do. Chronic pain more often than not interferes with sleep, prevents any signifi cant physical exercise, and adversely impacts the patient's ability to work and earn a living. Th ese things, in turn, adversely aff ect the patient's general health, mood, and personal relationships.
Eff ective documentation does not take much of an eff ort. It is simply a matter of adding a little bit more information. Something along these lines should be more than adequate and quite eff ective:
Mrs. Smith presents 15-month history of constant, severe localized pain in her lower back. She has been previously evaluated and found to have early degenerative changes in her lumbar spine. Surgery is an option, but the patient is concerned that it will not relieve her pain. She relates that this pain prevents her from standing at work and from any physical activity. Over the past 15 months she has gained 25 pounds and is worried about her hypertension getting worse. She also relates that her husband complains she is constantly irritable and never wants to do any of the activities they used to enjoy together.
With this backdrop, the practitioner is now able to justify initial treatment with medication and is set up to show the reasonable and benefi cial eff ect of that treatment at future visits. Th is initial history provides the practitioner the ability to show therapeutic benefi t in multiple ways. Benefi t can be shown through (a) something less than constant pain, (b) something less than severe pain, (c) the ability to work, (d) the ability to participate in physical activity, (e) weight loss, (f ) improved or stable blood pressure because of activity and/or weight loss, (g) improved mood, and/or (h) improved interpersonal relationships.
If one documents a thorough pain impact baseline from the outset, it is much easier to quickly document on future visits how treatment is benefi cial, i.e., that it is therapeutic. Th e key thing to remember and to document initially is how that pain adversely aff ects the patient on a day-to-day basis. Th en, on future visits, the practitioner can document how treatment has helped the patient improve on any elements of that initial baseline.
Along with the failure to document the eff ect of chronic pain and the impact of subsequent treatment, the most frequent defi ciency seen is absence of the required "treatment plan" (12) . While reason would dictate that it is intuitive-the "plan" is to treat the patient's pain with medication and allow improvement of the impact the pain has on other areas of the patient's lifekeep your audience in mind. Th e TMB and its reviewers are looking to see if this box can be checked off . If not, you will be criticized. Again, eff ective documentation does not need to be extensive. For example, a suffi cient plan might be: Particularly, when tailored to a well-documented history, this should be an adequate "initial" treatment plan. Th e adequacy of this treatment plan in the future will depend on the patient's history (i.e., whether the patient has had prior diagnostic studies and/or previously been evaluated for defi nitive treatment) and response to treatment. Keep in mind that your records must refl ect "periodic review" of the treatment plan (13) . On follow up, remember to focus on how the patient is progressing towards the treatment objectives, i.e., the baseline pain problems (14) . If improvement from baseline continues or is maintained, one is hard-pressed to claim treatment was not therapeutic or that the plan needs to be changed. Th is goes back to and emphasizes the "eff ect of chronic pain" issue discussed above, since that information provides the reasons why this patient's chronic pain merits treatment with medications, as opposed to some other "plan."
Th e guidelines' requirement for consultations and referrals is pretty subjective. Th e guidelines state that consultations and referrals should be obtained "as necessary" (15) . Th e guidelines also state that if you are dealing with a patient who has a history of substance abuse or a comorbid psychiatric disorder, consultation and referral "should be considered" (15) . Here again, the initial history is the key to meeting this requirement. In the event the patient has been previously tested and evaluated, and this is documented in the initial history, the necessity for consultation and referral should be relatively remote. If the patient has not had any prior testing or evaluation, consultation and referral might be more of a necessity.
When referrals and consultations are made, it is also important to document the patient's response to these recommendations, especially when they are not accepted by the patient. It is not unusual for a patient to decline the recommendation for a consultation or referral. Th ere are justifi ed and reasonable bases for declining these recommendations.
One justifi ed reason is the inability to pay for further evaluation and consultation. Th e fact of the matter is that a signifi cant increase in patient cost is associated with evaluation and treatment of various conditions that cause chronic pain. Computed tomography, magnetic resonance imaging, and other diagnostic studies are quite expensive, and the facilities that provide these services often demand a signifi cant amount of money up front, even from patients who are well insured. In addition, pain management and other specialists charge quite a bit more for offi ce visits than primary providers.
Another justifi ed reason for declining "defi nitive" treatment is that the patient does not want to run the risk that such treatment is unsuccessful. For example, the patient may have previously had a bad surgical experience. In fact, I can recall a specifi c instance in which the patient had multiple sources for her chronic pain, including chronic back pain and chronic pelvic pain. Th e patient had elected surgery in an eff ort to treat her pelvic pain, but the outcome was not very benefi cial. Given that experience, the patient understandably had no desire to undergo back surgery for the treatment of her back pain.
Whatever the reason, the key is to document why the patient declined other options, so that your decision to continue to treat the patient medically is justifi ed and reasonable. Absent documentation of a reason why the recommendation was not followed, a provider runs the risk that the "plan" is perceived as being nothing more than pushing drugs.
CONSIDERATIONS OUTSIDE OF THE GUIDELINES
Th e guidelines do not require written chronic pain agreements (16) but state only that a provider "should consider" use of such agreements as is reasonable under the circumstances (16) . Primary care organizations, however, now appear to favor the use of pain treatment agreements (17) . Th us, while the guidelines do not require the use of written agreements, it is probably in your best interest to have such an agreement with each of your chronic pain patients. Form agreements are available and easily accessible on the internet (18).
While not required by the guidelines, it is also probably a good idea to make (and document) eff orts to either (a) wean patients down/off of narcotic pain medications and/or (b) control their pain with nonnarcotic pain medications. Th ese eff orts are of particular importance when defi nitive treatment options are available to the patient, but the patient elects, for whatever reason, to not pursue those options. Absent these eff orts, you again run the risk that your treatment plan will be prejudicially viewed as nothing more than billing the patient for offi ce visits so that he or she can get medications.
CONCLUSION
Th ere are four key points to document when treating chronic pain patients: (a) their prior treatment history, (b) all facets of how their pain adversely aff ects them, (c) the reasons a medical management plan is reasonable, and (d) subsequently how that medical management plan helps the patient. Th e extra time and eff ort spent up front should make subsequent documentation easier because you already have a baseline from which it is easy to judge and document how the patient is responding to therapy, whether or not the plan is benefi ting the patient, and whether further consultation or referral is needed.
Th e irony about the use of medications to manage chronic pain is that this therapy is perceived to be and treated diff erently than other situations in which a legitimate medical condition is treated with long-term medication management. Th e reality is, however, that there is really nothing diff erent about using medications long term for pain management than there is for using medications long term for the treatment of other chronic medical conditions like diabetes, hyperlipidemia, and hypertension. Medications used for treatment of these conditions all have signifi cant potential side eff ects, including end-organ damage and death, just as with narcotics.
Th e sad thing about the situation with chronic pain patients is that regulatory bodies like the TMB place an undue burden on them, in contrast to other patients with chronic medical conditions. It is a sad fact that for many patients with diabetes, hyperlipidemia, and hypertension, those conditions are selfinfl icted. It is also a fact that the defi nitive treatment for these conditions is often something less risky than medications or surgery: i.e., diet and exercise. Th ese patients, and their providers, however, are not asked to forgo medication management because defi nitive and/or other less risky options exist.
In contrast, a patient's chronic pain is generally not selfinfl icted. It is often the result of an on-the-job injury or motor vehicle accident. Further, defi nitive treatment, i.e., surgery, often has signifi cant risks and may not resolve the patient's chronic pain. Why is it that these patients must forgo medications for a risky treatment that may not work? Something seems wrong here.
